MRK vs VG · P/E 33, rev $65.01B vs P/E 11, rev $13.77B
Merck & Company Inc (MRK) versus Venture Global, Inc. (VG) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Venture Global, Inc. (VG) is a oil & gas midstream company listed on NYSE.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported VG revenue for 2025-12-31 was $13.77B. Net income was $2.73B. Revenue was up 176.9% from 2024-12-31 to 2025-12-31. VG currently screens at market cap $26.69B and trailing P/E 11.2.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. VG currently screens at market cap $26.69B and trailing P/E 11.2.
Not investment advice. Open the MRK and VG stock pages for the full models.
Not investment advice.